2020 Race For Hope DC

Little Debbies

Team Little Debbie's was started in 2013, shortly after our mom, Debbie Schoenbauer, was diagnosed with the most aggresive form of brain cancer, Glioblastoma Multiforme. She did not allow her diagnosis to define or defeat her and defied the odds by battling this disease for 26 months, 20 months longer than her doctors at Johns Hopkins had originally estimated. Even through her initial diagnosis, brain surgery, an exhausting treatment regimine and a year and a half later encountering a tumor recurrence with a rigorous clinical trial, she never complained or waivered in her faith of God's plan for her. Our hearts are still grieving from our mom's passing on March 21, 2015 but we will strive to honor her and the legacy she has left behind. Please help us raise awareness and funds for the fight against brain tumors to find new and more effective, less invasive treatment plans. We'd love for you to join us on race day whether you choose to walk or run the beautiful 5k around our Nation's Capitol, however if you can't be with us that day we'd love for you to consider a donation to this incredible fundraiser that is near and dear to our hearts.



*Only 1% of national cancer funding goes directly towards brain tumors, urging us to raise awareness and to fight to make a difference in honor of our mom's battle with GBM.

*Brain tumors provoke profound personality changes in patients, they cause permanent disabilites with traumatic results.

*Brain tumors are most commonly treated by surgery, radiation and chemotherapy, all which can have devastating results in the patients physical and mental abilities.

*Little progress has been made in finding new and effective treatments in the past two decades.

*Glioblastoma Multiforme (GBM) is the most common and deadliest primary malignant brain tumor in adults

*More people under 40 die from a brain tumor than from any other cancer

*58% of men and women diagnosed with brain cancer die within a year 

*65% of GBM patients don't survive past one year and about 2% make it to their third year with the disease




View More